Aarhus Universitets segl

Mette Tranberg Nielsen

Clinical management of older postmenopausal women referred for colposcopy due to an abnormal screening test

Publikation: KonferencebidragKonferenceabstrakt til konferenceForskning

Standard

Clinical management of older postmenopausal women referred for colposcopy due to an abnormal screening test. / Nielsen, Mette Tranberg; Gustafson, Line Winther; Christiansen, Anne Gamst et al.

2021. Abstract fra EUROGIN 2021.

Publikation: KonferencebidragKonferenceabstrakt til konferenceForskning

Harvard

APA

CBE

MLA

Vancouver

Author

Bibtex

@conference{eef0b8aa0b114060b43539a8f9c28eec,
title = "Clinical management of older postmenopausal women referred for colposcopy due to an abnormal screening test",
abstract = "Background/Objectives: Background: In older postmenopausal women, performance of colposcopy is often inadequate due to theretraction of the transformation zone into the cervical canal. This challenges the colposcopic examination and the collection ofadequate cervical punch biopsies. Consequently, the {"}true{"} incidence of cervical precancer among older women may be underestimatedand may explain the observed discrepancy between incidence rates of cervical precancer and cervical cancer at older ages. The aim ofthis study was to describe the clinical management of Danish women aged 69+ who had been referred for colposcopy due to anabnormal screening test.Methods: Methods: We conducted a cohort study from January 2017 through December 2020. We included women who had beenreferred to gynecology departments in Central Denmark Region due to an abnormal screening test during 2017 (~200 women). Womenwere eligible if they were born before 1948 and had been invited for an additional HPV-based screening test. Women were excluded ifsmears had been obtained as part of follow-up due to previous abnormal screening tests. Information on colposcopic findings,behavioral risk factors, screening history, and results of subsequent cervical smears and biopsies until end of follow-up in December2020 were collected from medical records and the Danish Pathology Databank. Results will mainly be reported descriptively, and chi2and Fishers exact test will be used for comparison, as appropriate.Results: Results: Results will be presented at Eurogin 2021.Conclusions: Conclusion: This study will provide new and important evidence on how to clinically manage older postmenopausalwomen with abnormal screening tests, while balancing risk of underdiagnosis versus risk of overtreatment. Additionally, our resultsmay help identify areas of particular interest where more research is needed. ",
author = "Nielsen, {Mette Tranberg} and Gustafson, {Line Winther} and Christiansen, {Anne Gamst} and Helle Lapirtis and {Dueholm Hjorth}, {Ina Marie} and Lisa Krogh and Anne Hammer and Booth, {Berit Bargum}",
year = "2021",
month = jun,
day = "1",
language = "Dansk",
note = "EUROGIN 2021 ; Conference date: 30-05-2021 Through 01-06-2021",

}

RIS

TY - ABST

T1 - Clinical management of older postmenopausal women referred for colposcopy due to an abnormal screening test

AU - Nielsen, Mette Tranberg

AU - Gustafson, Line Winther

AU - Christiansen, Anne Gamst

AU - Lapirtis, Helle

AU - Dueholm Hjorth, Ina Marie

AU - Krogh, Lisa

AU - Hammer, Anne

AU - Booth, Berit Bargum

PY - 2021/6/1

Y1 - 2021/6/1

N2 - Background/Objectives: Background: In older postmenopausal women, performance of colposcopy is often inadequate due to theretraction of the transformation zone into the cervical canal. This challenges the colposcopic examination and the collection ofadequate cervical punch biopsies. Consequently, the "true" incidence of cervical precancer among older women may be underestimatedand may explain the observed discrepancy between incidence rates of cervical precancer and cervical cancer at older ages. The aim ofthis study was to describe the clinical management of Danish women aged 69+ who had been referred for colposcopy due to anabnormal screening test.Methods: Methods: We conducted a cohort study from January 2017 through December 2020. We included women who had beenreferred to gynecology departments in Central Denmark Region due to an abnormal screening test during 2017 (~200 women). Womenwere eligible if they were born before 1948 and had been invited for an additional HPV-based screening test. Women were excluded ifsmears had been obtained as part of follow-up due to previous abnormal screening tests. Information on colposcopic findings,behavioral risk factors, screening history, and results of subsequent cervical smears and biopsies until end of follow-up in December2020 were collected from medical records and the Danish Pathology Databank. Results will mainly be reported descriptively, and chi2and Fishers exact test will be used for comparison, as appropriate.Results: Results: Results will be presented at Eurogin 2021.Conclusions: Conclusion: This study will provide new and important evidence on how to clinically manage older postmenopausalwomen with abnormal screening tests, while balancing risk of underdiagnosis versus risk of overtreatment. Additionally, our resultsmay help identify areas of particular interest where more research is needed.

AB - Background/Objectives: Background: In older postmenopausal women, performance of colposcopy is often inadequate due to theretraction of the transformation zone into the cervical canal. This challenges the colposcopic examination and the collection ofadequate cervical punch biopsies. Consequently, the "true" incidence of cervical precancer among older women may be underestimatedand may explain the observed discrepancy between incidence rates of cervical precancer and cervical cancer at older ages. The aim ofthis study was to describe the clinical management of Danish women aged 69+ who had been referred for colposcopy due to anabnormal screening test.Methods: Methods: We conducted a cohort study from January 2017 through December 2020. We included women who had beenreferred to gynecology departments in Central Denmark Region due to an abnormal screening test during 2017 (~200 women). Womenwere eligible if they were born before 1948 and had been invited for an additional HPV-based screening test. Women were excluded ifsmears had been obtained as part of follow-up due to previous abnormal screening tests. Information on colposcopic findings,behavioral risk factors, screening history, and results of subsequent cervical smears and biopsies until end of follow-up in December2020 were collected from medical records and the Danish Pathology Databank. Results will mainly be reported descriptively, and chi2and Fishers exact test will be used for comparison, as appropriate.Results: Results: Results will be presented at Eurogin 2021.Conclusions: Conclusion: This study will provide new and important evidence on how to clinically manage older postmenopausalwomen with abnormal screening tests, while balancing risk of underdiagnosis versus risk of overtreatment. Additionally, our resultsmay help identify areas of particular interest where more research is needed.

M3 - Konferenceabstrakt til konference

T2 - EUROGIN 2021

Y2 - 30 May 2021 through 1 June 2021

ER -